Drug delivery to the posterior segments of the eye.
- 27 August 2001
- journal article
- editorial
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 52 (1) , 1-3
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a reviewJournal of Controlled Release, 2000
- Biodegradable scleral implant for intravitreal controlled release of ganciclovirGraefe's Archive for Clinical and Experimental Ophthalmology, 2000
- Tumor Infarction in Mice by Antibody-Directed Targeting of Tissue Factor to Tumor VasculatureScience, 1997
- Scleral Plug of Biodegradable Polymers for Controlled Drug Release in the VitreousArchives of Ophthalmology (1950), 1994
- Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS.British Journal of Ophthalmology, 1994
- Vascular targeting—a new approach to the therapy of solid tumorsPharmacology & Therapeutics, 1994
- Occlusion of retinal vessels using targeted delivery of a platelet aggregating agent.British Journal of Ophthalmology, 1993
- Sustained-Release Ganciclovir Therapy for Treatment of Cytomegalovirus RetinitisArchives of Ophthalmology (1950), 1992
- Intravitreal Sustained-Release GanciclovirArchives of Ophthalmology (1950), 1992